Gender-Specific Correlates of Complementary and Alternative Medicine Use for Knee Osteoarthritis

被引:21
作者
Jawahar, Rachel [1 ]
Yang, Shibing [1 ]
Eaton, Charles B. [2 ,3 ,4 ]
McAlindon, Timothy [5 ]
Lapane, Kate L. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23219 USA
[2] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA
[3] Brown Univ, Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, Pawtucket, RI 02860 USA
[4] Brown Univ, Warren Alpert Med Sch, Dept Family Med, Providence, RI 02912 USA
[5] Tufts Med Sch, Dept Rheumatol, Boston, MA USA
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; NATIONAL-HEALTH; SEX-DIFFERENCES; UNITED-STATES; TOTAL HIP; PAIN; ARTHROPLASTY; PREVALENCE; OVERWEIGHT; THERAPIES;
D O I
10.1089/jwh.2011.3434
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Knee osteoarthritis (OA) increases healthcare use and cost. Women have higher pain and lower quality of life measures compared to men even after accounting for differences in age, body mass index (BMI), and radiographic OA severity. Our objective was to describe gender-specific correlates of complementary and alternative medicine (CAM) use among persons with radiographically confirmed knee OA. Methods: Using data from the Osteoarthritis Initiative, 2,679 women and men with radiographic tibiofemoral OA in at least one knee were identified. Treatment approaches were classified as current CAM therapy (alternative medical systems, mind-body interventions, manipulation and body-based methods, energy therapies, and three types of biologically based therapies) or conventional medication use (over-the-counter or prescription). Gender-specific multivariable logistic regression models identified sociodemographic and clinical/functional correlates of CAM use. Results: CAM use, either alone (23.9% women, 21.9% men) or with conventional medications (27.3% women, 19.0% men), was common. Glucosamine use (27.2% women, 28.2% men) and chondroitin sulfate use (24.8% women; 25.7% men) did not differ by gender. Compared to men, women were more likely to report use of mind-body interventions (14.1% vs. 5.7%), topical agents (16.1% vs. 9.5%), and concurrent CAM strategies (18.0% vs. 9.9%). Higher quality of life measures and physical function indices in women were inversely associated with any therapy, and higher pain scores were positively associated with conventional medication use. History of hip replacement was a strong correlate of conventional medication use in women but not in men. Conclusions: Women were more likely than men to use CAM alone or concomitantly with conventional medications.
引用
收藏
页码:1091 / 1099
页数:9
相关论文
共 53 条
[1]  
ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3
[2]  
[Anonymous], 2020, WHO Technical Report Series 1004, Annex 9, 2017: World Health Organization
[3]  
Bell RA, 2006, ALTERN THER HEALTH M, V12, P16
[4]   Use of complementary and alternative therapies by overweight and obese adults [J].
Bertisch, Suzanne M. ;
Wee, Christina C. ;
McCarthy, Ellen P. .
OBESITY, 2008, 16 (07) :1610-1615
[5]   Intervention programs for arthritis and other rheumatic diseases [J].
Brady, TJ ;
Kruger, J ;
Helmick, CG ;
Callahan, LF ;
Boutaugh, ML .
HEALTH EDUCATION & BEHAVIOR, 2003, 30 (01) :44-63
[6]  
Callahan LF, 2009, PREV CHRONIC DIS, V6
[7]   Use of complementary and alternative therapies in community-dwelling older adults [J].
Cheung, Corjena K. ;
Wyman, Jean F. ;
Halcon, Linda L. .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2007, 13 (09) :997-1006
[8]   Clinical presentation of osteoarthritis in general practice: Determinants of pain in Italian patients in the AMICA study [J].
Cimmino, MA ;
Sarzi-Puttini, P ;
Scarpa, R ;
Caporali, R ;
Parazzini, F ;
Zaninelli, A ;
Marcolongo, R .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) :17-23
[9]   Differences in gait patterns, pain, function and quality of life between males and females with knee osteoarthritis: a clinical trial [J].
Debi, Ronen ;
Mor, Amit ;
Segal, Ofer ;
Segal, Ganit ;
Debbi, Eytan ;
Agar, Gabriel ;
Halperin, Nahum ;
Haim, Amir ;
Elbaz, Avi .
BMC MUSCULOSKELETAL DISORDERS, 2009, 10
[10]  
Dillon CF, 2006, J RHEUMATOL, V33, P2271